Molecular Partners AG

SWX:MOLN Stock Report

Market Cap: CHF 115.2m

Molecular Partners Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of MOLN?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,680,3144.49%
Public Companies1,739,1304.65%
Institutions3,604,2819.63%
Hedge Funds14,173,39837.9%
General Public16,214,54543.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 56.61% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
26.4%
BVF Partners L.P.
9,888,592CHF 30.5m0%1.12%
11.4%
Suvretta Capital Management, LLC
4,284,806CHF 13.2m0%0.42%
5.49%
UBS Asset Management AG
2,054,216CHF 6.3m-0.02%no data
4.65%
Novartis AG
1,739,130CHF 5.4m0%no data
2.49%
GAM Holding AG
930,343CHF 2.9m0%0.06%
2.03%
Patrick Amstutz
759,913CHF 2.3m0%no data
1.93%
Michael Stumpp
723,644CHF 2.2m0%no data
0.53%
Acatis Anlageberatung fur Investmentfonds GmbH
200,000CHF 616.0k0%0.05%
0.33%
Fourton Fund Management Co. Ltd
123,946CHF 381.8k0%0.22%
0.27%
BlackRock, Inc.
101,941CHF 314.0k2.74%no data
0.17%
LLB Asset Management AG
63,005CHF 194.1k0%0.01%
0.11%
Migrosbank Asset Management
41,529CHF 127.9k0%0.01%
0.11%
Philippe Legenne
41,316CHF 127.3k0%no data
0.11%
William Burns
40,922CHF 126.0k0%no data
0.091%
Renate Gloggner
34,025CHF 104.8k0%no data
0.084%
Swiss Life Asset Management AG
31,547CHF 97.2k0%no data
0.06%
Alexander Zurcher
22,571CHF 69.5k0%no data
0.054%
Steven H. Holtzman
20,258CHF 62.4k0%no data
0.042%
SmartHarvest Portfolios LLC
15,543CHF 47.9k26.3%0.02%
0.039%
Dimensional Fund Advisors LP
14,648CHF 45.1k37.6%no data
0.027%
Pictet Asset Management Limited
10,246CHF 31.6k0%no data
0.025%
State Street Global Advisors, Inc.
9,207CHF 28.4k0%no data
0.024%
Michael Vasconcelles
9,048CHF 27.9k0%no data
0.024%
Sandip Kapadia
9,048CHF 27.9k0%no data
0.024%
Vito Palombella
9,046CHF 27.9k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/26 02:41
End of Day Share Price 2026/05/26 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Molecular Partners AG is covered by 7 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Robert BurnsH.C. Wainwright & Co.
Richard VosserJ.P. Morgan
Wei ChangLeerink Partners LLC